By The Street Scout Staff
Recently our team has seen numerous job postings at a well-established boutique firm. As a result, we decided to dig a little deeper for our readers! Wolfe Research is an independent, institutionally focused sell-side firm. Ed Wolfe founded it in April 2008 after the collapse of Bear Stearns, leaving with a small team and launching a 10-person transports boutique. The firm has since grown into a full-service shop of roughly 250–300 people, with headquarters at 757 Third Avenue in New York and offices in Boston, San Francisco, Houston, London, and other cities. It now offers equity research, quantitative and strategy work (QES), sales, trading, alternative data, and selective capital-markets work through the Wolfe | Nomura alliance. In 2025, clients ranked Wolfe #6 on a weighted basis in the Extel All-America Research Poll, behind only much larger bulge-bracket firms.
The early years were narrow by design. Wolfe was a #1-ranked Airfreight & Surface Transportation analyst and built the firm around that franchise. He later concluded a single-sector shop could not serve clients through every cycle, so coverage expanded across industrials, energy, consumer, healthcare, financials, TMT, and macro. François Trahan joined in 2010 to lead strategy and later departed. In 2013 Wolfe handed his own sector to Scott Group and stopped covering stocks, an unusual move among boutique founders. A $4.5 million seed round in 2020 supported further growth. The firm’s pitch remains consistent: research comes first, not banking.
Apply through wolferesearch.com/careers, which routes to the BrightMove portal.
Key hires, past five years
Wolfe’s growth has come largely by recruiting ranked or specialist analysts and then giving them a research-first platform. The last five years show a clear pattern: deepen healthcare and TMT, add macro and policy, and backfill franchise seats when veterans retire.
2021–2022. Andrew Rosivach joined in February 2021 to build REITs coverage after a stint as EVP and Chief Credit Officer at STORE Capital and seven years leading REIT research at Goldman Sachs. Deepak Mathivanan arrived from Barclays as large-cap and SMID internet lead. Joshua Tilton joined from Berenberg in July 2021 to cover security software. In 2022, Mike Polark came from Baird to cover medical supplies and devices out of Boston, and Peter Supino left Bernstein to cover cable, satellite, telecom, and media after earlier buy-side roles at Passport Capital and Weitz.
2023. Chris Caso joined in July from Credit Suisse to cover semiconductors and semi cap equipment, bringing both sell-side and industry engineering experience. Macro was built out the same year: Tobin Marcus joined in September from Evercore ISI as Head of Policy & Politics; Doug Schenkel arrived in October from DELFI Diagnostics (and previously Cowen) as Head of Life Science & Diagnostic Tools; and Stephanie Roth joined in November as Chief Economist from J.P. Morgan Private Bank and, before that, Cornerstone Macro. Roth later ranked as an Extel runner-up; Marcus’s policy team ranked #3 in 2025.
2024. The biggest internal hire was Daire Browne, who joined in September as Global Head of Research from Bank of America, where he ran Americas Equity Research. Emmanuel Rosner arrived in August from Deutsche Bank to cover autos, parts, and auto technology, succeeding Hall of Fame analyst Rod Lache after Lache’s 32-year career, including six years at Wolfe. Alexandria Hammond joined in October as Head of Therapeutics Research. Trevor Allinson took homebuilders and building products.
2025–2026. Tracy Dolin-Benguigui joined in June 2025 to cover life and non-life insurance after heading insurance equity research at Barclays and a long stretch at S&P Global Ratings. George Notter joined the same month as a managing director covering communications infrastructure—networking and telecom gear tied to data centers, cloud, and AI. Kalpit Patel arrived in October 2025 from B. Riley to cover SMID biotech in oncology and rare disease. In February 2026, Dr. Rudy Li joined from Chardan (and earlier Leerink) to cover CNS-focused biotech. Those three healthcare adds sit alongside Hammond, Andy Chen, Polark, Schenkel, and Justin Lake.
Current openings
Most research seats are New York hybrid. Typical associate requirements include a strong academic record (often 3.5+ GPA), financial modeling and writing, long hours, and Series 7, 63, 86, and 87 licenses—or a plan to finish them within six months. Prior research, banking, accounting, consulting, or industry experience is preferred.
Research roles now listed:
- Equity Research Associate, SMID Biotech (about $95k–$130k)
- Equity Research Senior Associate, Global Pharmaceuticals & Large Cap Biotech
- Equity Research Associate, REITs (about $90k–$100k)
- Equity Research Associate, Midstream & Natural Gas (about $95k–$120k)
- Equity Research Associate, Oil & Gas, New York or Houston (about $95k–$115k)
- Equity Research Associate / Senior Associate, Chemicals, Agriculture & Packaging (about $110k–$130k)
Sales, data, and support:
- Equity Sales Assistant, New York hybrid, with some Boston listings (about $80k–$90k)
- Data Analytics Analyst, Equity Sales, San Francisco (about $80k–$120k)
- Equity Research Coordinator, sell-side (about $80k–$90k)
- Executive Assistant, New York
- Vice President, Assistant Controller, GAAP Accounting (about $150k–$180k)
Job boards have also recently carried Homebuilding, Insurance, Consumer, Internet senior associate or VP, Management Associate, Fund Controller, and Alternative Asset Management MD roles. Confirm what is live on the official portal before applying. Listings move quickly.
Founder and management
Ed Wolfe, Managing Partner, has run the firm since day one. He holds a Georgetown B.A. and a Fordham J.D., worked as a litigator including at Legal Aid in the Bronx, and co-founded an apparel company before Wall Street. His sell-side path ran through Schroder Wertheim, BT Alex Brown, Deutsche Bank, and Bear Stearns. He made Institutional Investor’s All-America team for 14 years. He chairs the Executive and Operating Committees and still drives hiring, strategy, and culture.
Mackenzie Fulk, President, joined in 2008 from UBS. A Georgetown McDonough graduate, he helped build the institutional platform, served as Co-Head of Global Institutional Sales from 2016 to 2019, and remains the lead contact for firm partnerships. He sits on both committees.
Daire Browne, Global Head of Research, arrived in September 2024 from Bank of America, where he ran Americas Equity Research after serving as COO of Global Research. He was a founding investor in Visible Alpha. He holds a Bachelor of Commerce from University College Dublin and a master’s from Dublin City University. He owns the research product.
Jon Stenzler, Global Head of Sales and a principal, came from Evercore ISI after a decade at Citigroup and earlier work as a journalist at The Philadelphia Inquirer. He holds degrees from Lafayette, NYU, and Columbia Business School and is based in San Francisco.
Yin Luo, Vice Chairman and head of QES, joined in 2016 from Deutsche Bank, where he was Global Head of Quantitative Strategy. Clients ranked him #1 in quantitative research in Extel 2025 and #1 or #2 for about 15 years. He is an adjunct professor at Columbia, a member of FASB’s advisory council (FASAC), and holds CFA, CPA, CGMA, and PStat credentials.
Scott Group, a founding member and senior analyst, covers freight transportation, airlines, and truck machinery. He is in Extel’s All-America Research Hall of Fame after 10 years at #1 in Airfreight & Surface Transportation. He came from Bear Stearns and, before that, Merrill Lynch, and earned his degree at Wharton. He took over Wolfe’s original sector when the founder stepped off coverage.
Other senior operators include Alicia Devan (COO), Frank Jordan (CFO), Sandra Pallante (General Counsel), Dina Blumenfeld (Head of HR; joined 2021 from Nomura after BofA and Morgan Stanley), and Peter Ryan (Head of Capital Markets). Senior analysts Greg Badishkanian and Steve Fleishman also sit on the Executive Committee.